2026 annual financial data
Sonoma Pharmaceuticals 2026 Operating margin
Sonoma Pharmaceuticals 2026 operating margin with verified reported values.
Direct answer
Operating margin was -12.6%.
Operating income was -2,461,000 USD and net income was -3,175,000 USD.
Operating cash flow was -3,933,000 USD.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,529,000 USD
- Operating income
- -2,461,000 USD
- Net income
- -3,175,000 USD
- Operating cash flow
- -3,933,000 USD